Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72804 record(s)

Req # A-2020-001613

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115165-386.

Organization: Health Canada

27 page(s)
January 2024

Req # A-2021-000440

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100203-189, Status of the use of Remotely Piloted Aircraft Systems (drones) for pesticide application in Canada.

Organization: Health Canada

9 page(s)
January 2024

Req # A-2021-001103

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075341-120.

Organization: Health Canada

37 page(s)
January 2024

Req # A-2021-001626

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_04099915, E2B_04220499, E2B_04291634, E2B_04207144, E2B_04127965, E2B_00900035, E2B_04205769, E2B_04306647, E2B_04309070, E2B_04337015, E2B_04337025, E2B_04325809, E2B_04325034,…

Organization: Health Canada

752 page(s)
January 2024

Req # A-2021-001787

Adverse Drug Reaction (ADR) for AGALSIDASE BETA. Report number: E2B_04595165.

Organization: Health Canada

15 page(s)
January 2024

Req # A-2021-001971

Adverse Drug Reactions (ADRs). Report numbers: 000637837, 000682834, E2B_02062357, 000715854, 000686654.

Organization: Health Canada

36 page(s)
January 2024

Req # A-2022-000123

Adverse Drug Reaction (ADR) for ALFUZOSIN HYDROCHLORIDE. Report number: E2B_05007203.

Organization: Health Canada

12 page(s)
January 2024

Req # A-2022-000132

Adverse Drug Reactions (ADRs). Report numbers: E2B_05040768, E2B_05047160, E2B_05045863, E2B_05040989, E2B_05045885, E2B_05047233, E2B_05047201, E2B_05046993 E2B_05040639, E2B_05046996.

Organization: Health Canada

152 page(s)
January 2024

Req # A-2022-000178

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-100947-72.

Organization: Health Canada

7 page(s)
January 2024

Req # A-2022-000350

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-102527-380.

Organization: Health Canada

7 page(s)
January 2024
Date modified: